Chronic Kidney Disease (CKD) clinical trials in New York
34 active Chronic Kidney Disease (CKD) trials with a site in New York. Describe your situation to see which ones look like a fit.
- A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis
- A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
- Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Chronic Kidney Disease (CKD)
- Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Oral Iron in Children With Chronic Kidney Disease
- Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
- Ferric Citrate and Chronic Kidney Disease in Children
- A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
- A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Transcutaneous Auricular Vagus Nerve Stimulation Device in CKD Population
- Accelerated Age-related Cognitive Decline: Impact of Exercise on Executive Function and Neuroplasticity
- A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
- A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis
- Pivotal Study of the Velocity™ pAVF System
- A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
- Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease
- SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
- Combination of Novel Therapies for CKD Comorbid Depression
- A Study of Luspatercept in People With Anemia
- An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant
- Real World Evidence Clinical Utility Study of KidneyIntelX
- Transformative Research in Diabetic Nephropathy
- Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.
- Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)
- Interventions for Promoting Kidney Transplant Empowerment
- Community Health Workers in an Interdisciplinary Outpatient CKD Clinic to Optimize Social Care Navigation, Patient Engagement, and Home Dialysis Utilization
- Chronic Kidney Disease-Education (CKD-EDU)
- Hybrid Dissemination Study of A Digital-Analog Intervention to Increase Live Donor Kidney Transplantation
- Selatogrel Outcome Study in Suspected Acute Myocardial Infarction
- Expanding and Promoting Alternative Care and kNowledge in Decision-making Trial
- Renal Allograft Fibrosis Study
- Truway Diagnostic Tools in Primary Care
- Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
- A Study to Learn How Safe and Tolerable Vonsetamig is in Adult Patients With Chronic Kidney Disease (CKD) Who Need Kidney Transplantation and Are Highly Sensitized to Human Leukocyte Antigen (HLA)
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.